Strengthening Bordetella pertussis genomic surveillance by direct sequencing of residual positive specimens
Journal of Clinical Microbiology · 10.04.2024 · 62 (4)
DOI: 10.1128/jcm.01653-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Microbiology, erschienen am 10.04.2024. Verfasst von Yanhui Peng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georg…. Hauptthemen laut MEDLINE: Whooping Cough, Bordetella. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Whole-genome sequencing (WGS) of microbial pathogens recovered from patients with infectious disease facilitates high-resolution strain characterization and molecular epidemiology. However, increasing reliance on culture-independent methods to diagnose infectious diseases has resulted in few isolates available for WGS. Here, we report a novel culture-independent approach to genome characterization of Bordetella pertussis , the causative agent of pertussis and a paradigm for insufficient genomic surveillance due to limited culture of clinical isolates. Sequencing libraries constructed directly from residual pertussis-positive diagnostic nasopharyngeal specimens were hybridized with biotinylated RNA “baits” targeting B. pertussis fragments within complex mixtures that contained high concentrations of host and microbial background DNA. Recovery of B. pertussis genome sequence data was evaluated with mock and pooled negative clinical specimens spiked with reducing concentrations of either purified DNA or inactivated cells. Targeted enrichment increased the yield of B. pertussis sequencing reads up to 90% while simultaneously decreasing host reads to less than 10%. Filtered sequencing reads provided sufficient genome coverage to perform characterization via whole-genome single nucleotide polymorphisms and whole-genome multilocus sequencing typing. Moreover, these data were concordant with sequenced isolates recovered from the same specimens such that phylogenetic reconstructions from either consistently clustered the same putatively linked cases. The optimized protocol is suitable for nasopharyngeal specimens with diagnostic IS 481 Ct < 35 and >10 ng DNA. Routine implementation of these methods could strengthen surveillance and study of pertussis resurgence by capturing additional cases with genomic characterization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
- ASRT Inc., Atlanta, Georgia, USA.
ORCID-Profile: Yanhui Peng, Margaret M Williams, Lingzi Xiaoli, Ashley Simon, Heather Fueston, Maria L Tondella, Michael R Weigand
Zitieren
APA
Peng, Y., Williams, M. M., Xiaoli, L., Simon, A., Fueston, H., Tondella, M. L., & Weigand, M. R. (2024). Strengthening Bordetella pertussis genomic surveillance by direct sequencing of residual positive specimens. Journal of Clinical Microbiology, 62(4). https://doi.org/10.1128/jcm.01653-23
Vancouver
Peng Y, Williams MM, Xiaoli L, Simon A, Fueston H, Tondella ML, et al. Strengthening Bordetella pertussis genomic surveillance by direct sequencing of residual positive specimens. Journal of Clinical Microbiology. 2024;62(4). doi:10.1128/jcm.01653-23
BibTeX
@article{Peng2024,
author = {Peng, Yanhui and Williams, Margaret M and Xiaoli, Lingzi and Simon, Ashley and Fueston, Heather and Tondella, Maria L and Weigand, Michael R},
title = {Strengthening Bordetella pertussis genomic surveillance by direct sequencing of residual positive specimens},
journal = {Journal of Clinical Microbiology},
year = {2024},
volume = {62},
number = {4},
doi = {10.1128/jcm.01653-23}
}
EUVIMED